Infectious Disease Advisor Real-world use of nirmatrelvir-ritonavir was associated with substantially lower rates of COVID-19-related hospitalization among high-risk outpatients during the Omicron…
Nirmatrelvir-Ritonavir Significantly Lowers Risk for COVID-19-Related Hospitalization | The Transmission
